Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Summary of Non Vested Awards) (Details)

v3.20.2
Stock-Based Compensation and Other Benefit Plans (Summary of Non Vested Awards) (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 1 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Restricted Stock [Member]    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Outstanding at January 1, 2020 | shares   343
Awards granted | shares   971
Awards vested | shares   (145)
Outstanding at March 31, 2020 | shares 1,169 1,169
Weighted Average Grant Price, Outstanding at January 1, 2020   $ 1.52
Weighted Average Grant Price, Awards granted $ 1.23 1.23
Weighted Average Grant Price, Awards vested   1.39
Weighted Average Grant Price, Unvested awards forfeited  
Weighted Average Grant Price, Outstanding at March 31, 2020 $ 1.30 $ 1.30
Stock Appreciation Rights (SARs) [Member]    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Outstanding at January 1, 2020 | shares   3,418
Awards granted | shares  
Awards exercised | shares  
Unvested awards forfeited | shares   (60)
Vested shares expired | shares  
Outstanding at March 31, 2020 | shares 3,358 3,358
Exercisable at March 31, 2020 | shares 2,177 2,177
Weighted Average Grant Price, Outstanding at January 1, 2020   $ 1.30
Weighted Average Grant Price, Awards granted  
Weighted Average Grant Price, Awards exercised  
Weighted Average Grant Price, Unvested awards forfeited   1.83
Weighted Average Grant Price, Vested shares expired  
Weighted Average Grant Price, Outstanding at March 31, 2020 $ 1.29 1.29
Weighted Average Exercise Price Per Share, Exercisable at March 31, 2020 $ 1.16 $ 1.16
Term (in years), Outstanding at March 31, 2020   2 years 7 months 24 days
Term (in years), Exercisable at March 31, 2020   2 years 4 months 9 days
Aggregate Intrinsic Value, Outstanding at March 31, 2020 | $ $ 709 $ 709
Aggregate Intrinsic Value, Exercisable at March 31, 2020 | $   $ 485